OBJECTIVES: Ex vivo lung perfusion (EVLP) is not only used to assess marginal donor lungs but is also used as a platform to deliver therapeutic agents outside the body. We previously showed the beneficial effects of trimetazidine (TMZ) on ischaemia reperfusion (IR) injury in a rat model. This study evaluated the effects of TMZ in a pig EVLP transplant model.
INTRODUCTION
Ex vivo lung perfusion (EVLP) is the most significant advancement in lung transplantation in the last decade. EVLP was initially developed by Steen et al. [1] in 2001 to evaluate lungs from donation after cardiac death donors. The Toronto group advanced the protocol and showed its safety and efficacy in the assessment of high-risk donor lungs in clinical settings [2] . Since then, EVLP has been used not only to evaluate but also to recondition marginal donor lungs before transplantation [3] [4] [5] . Lung transplant programmes have reported increased lung utilization rates with the implementation of EVLP; this was mainly related to the use of EVLP for reassurance, prior to the use of questionable donor lungs [6] [7] [8] . There are few case reports on the successful use of active treatment strategies during EVLP to salvage donor lungs in the clinical setting [9] .
Airway and vascular routes can be used to deliver therapeutic agents during EVLP for reconditioning injured lungs to prevent ischaemia reperfusion (IR) injury in lung transplantation [10, 11] . IR injury is the most common and important cause of primary graft dysfunction (PGD) [12] . PGD is the main cause of early morbidity and mortality after lung transplantation, affecting up to 20% of recipients [13] . The 30-day mortality rate can increase to 30%, depending on the severity of PGD [14] . In addition, patients who survive at least 12 months after severe PGD have significantly impaired physical function and increased the risk of developing chronic lung allograft dysfunction [15] .
Trimetazidine (TMZ) is an antianginal agent that has been prescribed to improve exercise tolerance and cardiac function in patients with ischaemic heart disease [16, 17] . TMZ switches energy substrate preference from fatty acid oxidation to glucose oxidation, which increases adenosine triphosphate (ATP) synthesis during ischaemia [18, 19] . TMZ also inhibits mitochondrial permeability transition pore (mPTP) opening and prevents lethal IR injury by protecting mitochondrial integrity and preventing apoptosis [16] [17] [18] . Various studies have reported the effects of TMZ in preventing IR injury in the kidney and heart [16] [17] [18] [19] . We previously demonstrated the beneficial effects of TMZ in reducing IR injury in rat transplant models [16, 17] .
In this study, we hypothesized that the ex vivo administration of TMZ prevents IR injury after lung transplantation. The study objective was to test the feasibility and efficacy of vascular administration of TMZ during EVLP in a pig lung transplantation model.
MATERIALS AND METHODS

Animal care
The animal use protocol was approved by the local authorities under license number ZH 277/2014. Experiments were performed in conformity with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, 2011).
Twenty domestic pigs (28-35 kg) were used. All animals were premedicated with an intramuscular injection of 20 mg/kg ketamine (Ketasol-100; Dr E. Graeub AG, Berne Switzerland), 1-2 mg/kg azaperone (Stresnil, Provet AG, Lyssach Switzerland) and 0.1-0.2 mg/kg atropine sulphate 0.1%. All animals were intubated and ventilated with an inspired oxygen fraction of 0.5, tidal volume of 8-10 ml/kg, a frequency of 20 breaths/min, and a positive end-expiratory pressure (PEEP) of 5 mbar. Anaesthesia was maintained with isoflurane and continuous infusion of propofol (2-5 mg/kg/h; Propofol-Lipuro 1%; Braun Medical AG, Sempach, Switzerland). Animals were placed on the operating table in supine and right lateral recumbent positions for the donor and recipient procedures, respectively.
Administration of trimetazidine
Cau et al. [20] have used 5 and 10 mg/kg of TMZ to achieve decreased inflammatory response, reduced apoptosis and enhanced renal function in an ischaemic kidney injury model. Inci et al. [21] have administered 5 mg/kg of TMZ intravenously prior to reperfusion in lung transplantation. In this study, we also used 5 mg/kg TMZ (Vastarel, 20 mg/ml liquid; Laboratory Servier, France) added to the prime solution prior to initiation of EVLP.
Study design
The study consisted of control (CON) and TMZ treatment groups (n = 5 each). The donor lungs were retrieved and stored for 24 h at 4 C. Then, the grafts were randomly allocated into study groups and underwent EVLP for 4 h. In the TMZ group, 5 mg/kg of TMZ were added to the prime solution. At the end of EVLP, the left lung was transplanted. At the end of 4 h of reperfusion time, the right pulmonary artery (PA) was occluded, and a systemic arterial blood sample was taken after 10 min (Fig. 1) .
Donor procedure
After general anaesthesia, a median sternotomy was performed and thymus tissue was excised. The pleural cavities and pericardium were opened. The superior and inferior vena cava were encircled. Sodium heparin (300 IU/kg) was given intravenously. The main PA was cannulated with a 24-Fr catheter. The superior and inferior vena cava were ligated, the left atrial appendage was transected and the PA was flushed with 50 ml/kg of organ preservation solution (Perfadex V R , XVIVO Perfusion, Uppsala, Sweden) at 4 C from a height of 30 cm above the heart. Ventilation was continued throughout the extraction of the heart-lung block. The trachea was clamped, and the block was removed from the chest cavity. After the heart was excised, retrograde flushing was performed via the atrial cuff. The lungs were then placed in a plastic bag containing 500 ml of Perfadex V R solution, double bagged and stored at 4 C for 24 h.
Priming the ex vivo circuit and preparation for ex vivo lung perfusion
The circuit was primed with 1.5 l of Steen V R solution (XVIVO Perfusion). Sodium heparin (10 000 IU), meropenem (500 mg) and methylprednisolone (500 mg) were added to the perfusate. An additional 5 mg/kg of TMZ were added to the prime solution in the treatment group.
A specially designed funnel-shaped cannula was used for the left atrium. The cannula was sewn to the left atrium using 4-0 Prolene suture. Afterwards, the main PA and trachea were cannulated using a straight cannula, and a size 8 endotracheal tube was placed in the tracheal stump and tightened. Retrograde flushing was performed with 500 ml of Perfadex V R at the back table. After deairing, the left atrium and PA cannulas were connected to the EVLP circuit. C, followed by 4 h of EVLP. TMZ (5 mg/kg) were added to the prime solution prior to EVLP in the treatment group. CON group lungs underwent EVLP according to the standard protocol. After EVLP, the left lungs were orthotopically transplanted. At the end of 4 h of reperfusion, the right PA was occluded for 10 min to assess isolated lung function. CIT: cold ischaemic time; CON: control group; EVLP: ex vivo lung perfusion; PA: pulmonary artery; TMZ: trimetazidine.
Ex vivo lung perfusion
EVLP was performed for 4 h. At the beginning, cardiac output was calculated as 0.01 Â kilogram body weight. The maximal flow attained was 40% of the cardiac output. Anterograde flow was started at 20 C with 10% of maximal flow. Temperature and flow were gradually increased to 37 C and 100% of maximal flow in the first hour. At 32 C, mechanical ventilation was started. The lungs were ventilated with a protective mode (tidal volume of 7 ml/kg, PEEP of 5 mbar and inspired oxygen fraction of 21%). A recruitment manoeuvre was performed hourly with a stepwise increase in tidal volume until peak airway pressure of 25 mbar was achieved. Arterial and venous blood gases were sampled and airway and vascular pressures were recorded hourly. Delta (D) PaO 2 , pulmonary vascular resistance and dynamic lung compliance were measured. At the end of 4 h of EVLP, the right lung was sampled and stored at -80 C for further analysis. A bronchoalveolar lavage (BAL) sample was collected from the right lower lobe.
Transplantation procedure
Baseline haemodynamic measurements and arterial and mixed venous blood gas analyses were recorded after induction of anaesthesia. Following left anterolateral thoracotomy, the right PA was encircled, and then a left pneumonectomy was performed. Donor lung was placed into the thoracic cavity, and bronchial, PA and atrial anastomoses were completed.
Graft parameters
Systemic and pulmonary venous gases were sampled, along with lung compliance measurements every hour. At the end of 4 h of reperfusion, the right PA was occluded and systemic arterial blood was sampled after 10 min.
Thiobarbituric acid-reactive substances
Quantitative measurement of lipid peroxidation [malondialdehydethiobarbituric acid-reactive substances (MDA-TBARS) reaction] was performed using a colorimetric/fluorometric assay kit (Biovision, Inc., Milpitas, CA, USA) according to the manufacturer instructions, and the results were expressed in nanomoles per milligram.
Myeloperoxidase activity
Myeloperoxidase (MPO) activity was measured using a kit (BioVision Inc.) according to the instructions, and the results were expressed in milli units per milligram.
ATP level
Frozen lung tissue (25 mg) was homogenized in 0.5 ml of 0.5% trichloroacetic acid. The homogenate was centrifuged at 8000 rpm for 2 min at 4 C. The supernatant was removed, and 10 ml of 0.002% xylenol blue was added. Tris-acetate was used to neutralize the pH to 7.4. ATP concentration in the supernatant was determined enzymatically with an ATP assay kit (Enliten V R ;
Promega, Madison, WI, USA). The results were expressed in nanomolar per milligram of ATP.
Protein assay in bronchoalveolar lavage
Protein concentration in BAL was determined using a micro bicinchoninic acid kit (Thermo Fisher Pierce, Rockford, IL, USA) using bovine serum albumin as a standard according to the manufacturer's protocol. Results were expressed in microgram per millilitre.
Lung pathology and TUNEL staining
End-EVLP and end-reperfusion tissue samples were collected, fixed in formalin and embedded in paraffin. Tissue sections were stained with haematoxylin and eosin for microscopic assessment. Lung injury was assessed according to the American Thoracic Society scoring system [22] . A terminal deoxynucleotidyl transferase deoxyuridine triphosphatase nick-end labelling (TUNEL) assay kit was used to evaluate apoptosis in lung tissue sections. Staining was performed according to the manufacturer's instructions. The cytoplasm of apoptotic cells contained red granules. The number of apoptotic cells in 5 random high-power fields (Â400) was calculated. The apoptotic index was expressed as the number of apoptotic cells/100 cells (%).
Statistical analysis
Data analysis was performed using SPSS V R (IBM, Armonk, NY, USA). All data were expressed as mean ± standard deviation (SD). The Mann-Whitney U-test was utilized to compare variables between the 2 groups. Repeated-measures analysis of variance was performed to evaluate the differences in physiological parameters between 2 groups over the 4-h EVLP and reperfusion periods. A P-value <0.05 was considered significant.
RESULTS
Preoperative parameters
Preoperative characteristics, including donor and recipient body weights, oxygenation before surgery, cold ischaemic time and ratio of arterial partial pressure of oxygen to inspired oxygen fraction at the beginning of EVLP did not differ significantly between the 2 groups (Table 1) .
Lung function
Compared with the CON group, the TMZ group showed a trend towards better oxygenation during EVLP (P = 0.057; Fig. 2A ). Dynamic lung compliance ( Fig. 2B ; P = 0.93) and pulmonary vascular resistance ( Fig. 2C ; P = 0.21) were comparable between the 2 groups.
Following transplantation, dynamic compliance did not differ significantly between the 2 groups ( Fig. 3A ; P = 0.13). Pulmonary gas exchange was significantly better throughout reperfusion in the TMZ group than in the CON group ( Fig. 3B left panel ; P < 0.05). After clamping the right PA, systemic oxygenation was also markedly better in the TMZ group ( Fig. 3B right panel; TMZ: 72 ± 4.5 vs CON: 34.7 ± 24 kPa; P < 0.05). Seven pigs had tachycardia and 2 had cardiac arrest in this period.
Thiobarbituric acid-reactive substances
MDA-TBARS levels were significantly higher in the CON group than in the TMZ group at the end of EVLP ( 
Myeloperoxidase
Similarly, MPO levels were significantly higher in the CON group than in the TMZ group at the end of EVLP (Fig. 4B , left panel; CON: 0.6 ± 0.14 vs TMZ: 0.25 ± 0.17 mU/mg; P < 0.05). Although MPO levels were higher in the CON group, the difference did not reach statistical significance at the end of reperfusion ( 
ATP levels
Even though ATP levels were higher in the TMZ group, the difference was not statistically significant, at both end-EVLP ( Fig. 4C left  panel; CON: 183.78 ± 26.74 vs TMZ: 275.2 ± 125.8 nmol/mg; P = 0.3) and end-reperfusion ( Fig. 4C right panel; CON: 371.25 ± 145 vs TMZ: 376.64 ± 118.5 nmol/mg; P = 0.9) time points.
Protein levels in bronchoalveolar lavage
Total protein concentration in BAL samples was markedly lower in the TMZ group after EVLP than in the CON group ( Fig. 4D left panel;  CON: 10.8 ± 6.9 vs TMZ: 3.8 ± 4.6 mg/ml; P < 0.05). However, the difference did not reach statistical significance at the end of reperfusion ( Fig. 4D right panel; CON: 4 ± 2.5 vs TMZ: 2.1 ± 1 mg/ml; P = 0.22).
Pathology
Although microscopic lung injury scoring did not reach statistical significance, tissue sections in the TMZ group showed less inflammatory cell infiltration and alveolar haemorrhage than the controls. Figure 5 shows representative images.
Similarly, as determined by TUNEL staining, there was less apoptotic cell infiltration in the TMZ group than in the control. Figure 6 shows representative images.
DISCUSSION
The present study showed that ex vivo treatment of donor lungs with TMZ improved immediate post-transplant lung function and protected the allografts against IR injury in a pig model. TMZ has multiple therapeutic benefits, including regulation of energy stores and cell death pathways and anti-inflammatory properties. Ischaemia depletes ATP stores and causes ion pump failure. As a result of loss in cellular membrane potential, intracellular sodium ion accumulation and potassium ion leakage occur, which results in cell swelling, interstitial fluid accumulation and increased diffusion distance [16, 17] . Intracellular calcium ion accumulation begins during ischaemia and is further increased during reperfusion [18, 19] . Increased intracellular calcium ion accumulation, abrupt pH restoration and an increase in reactive oxygen metabolites lead to mPTP opening. mPTP is a mega channel at the inner mitochondrial membrane, which initiates mitochondrial apoptosis [16] [17] [18] [19] .
Beneficial effects of TMZ on IR injury have previously been shown for the heart and kidney [22] [23] [24] . Various mechanisms are involved in these beneficial effects. TMZ switches energy substrate preferences from fatty acid oxidation to glucose oxidation, thereby increasing ATP synthesis during ischaemia [18, 19] . TMZ also decreases the activity of the electron transport chain complex during ischaemia and reduces oxygen consumption and reactive oxygen species production [18, 19] . TMZ limits intracellular acidosis and reduces sodium and calcium accumulation in cells [23] . TMZ inhibits mPTP opening and prevents lethal IR injury by protecting mitochondrial integrity and preventing apoptosis [17] [18] [19] .
We added TMZ 5 mg/kg to the prime solution prior to initiation of EVLP. TMZ administered intravenously has a short halflife (1.18 ± 0.15 h) in pigs [24] . Because TMZ is excreted by the kidney, we anticipated that the half-life would be longer during EVLP and demonstrated this by using liquid chromatographyselected reaction monitoring/mass spectrometry to quantitate TMZ. Despite a reduction after priming during the first hour (40%), levels were stable during EVLP.
Measuring end products of lipid peroxidation is useful for the evaluation of oxidative damage [25] . In this study, we showed that lipid peroxidation determined by an MDA-TBARS reaction was significantly lower in the TMZ group at the end of EVLP than in the CON group. However, lipid peroxidation was comparable for both groups at the end of the reperfusion period.
The correlation between increased MPO activity, as an indicator of neutrophil activation, and IR injury has been shown [26] . In this study, MPO activity after EVLP was significantly lower in the TMZ group than in the CON group. However, the difference was not significant at the end of reperfusion. This might be explained as the effect of TMZ during EVLP but not during the reperfusion period. In order to demonstrate this, TMZ should also have been given during the reperfusion period.
Total protein concentration in BAL should reflect the accumulation of extravascular protein due to increased alveolocapillary membrane permeability [22, 27] . In our study, BAL protein assay results were significantly lower in the TMZ group than in the CON group.
Inhibition of b-oxidation and increasing glucose utilization decreases oxygen consumption during ischaemia [18, 19] . TMZ also prevents the opening of the mPTP pore [16] [17] [18] [19] [20] [21] and preserves mitochondrial integrity [19] , leading to high ATP levels during reperfusion. Our results are in accordance with those of previous studies.
We previously reported that TMZ-treated recipient groups show significantly better oxygenation and ATP levels and lower rates of IR injury in a rat transplant model [16, 17] . EVLP not only allows evaluation of donors but also can be used as a new platform for treatment of lungs before transplantation [5] [6] [7] . Transplant after EVLP using large animals most accurately reflects clinical responses [28] . This study showed a protective effect against IR lung injury in the treatment group.
Limitations
One of the limitations of our study was the short observation time after transplantation, especially after clamping the contralateral PA. Animals often had cardiac problems due to right-sided heart failure, a well-known complication of this model. Survival models provide more insight on long-term results. Accordingly, we plan to perform a study with TMZ, using a survival model. Another limitation was related to physiological assessments. We observed significantly better oxygenation results in the treatment group during the reperfusion period, but this was not correlated with lung compliance. This might be due to not excluding the right main bronchus from ventilation in this model. Another explanation for this result is the higher airway pressures that were observed in each group. 
CONCLUSION
In conclusion, we demonstrated that ex vivo administration of TMZ during EVLP protected transplanted lungs against IR injury via inhibition of neutrophil activation, lipid peroxidation and alveolocapillary membrane permeability. Further studies are warranted to understand the effect of this strategy on long-term lung function in this setting.
